Fig. 1From: A proof-of-concept study to evaluate the efficacy and safety of BTI320 on post-prandial hyperglycaemia in Chinese subjects with pre-diabetesChanges in serum fructosamine levels from baseline in low dose BTI320, high dose BTI320 and placebo groupsBack to article page